WHO announced nulti-country mpox outbreak in non-endemic countries
On May 21, 2022, the World Health Organization (WHO) announced that since May 13, 2022, cases of mpox…
-
-
WHO informed of a confirmed case of mpox in an individual who travelled from the United Kingdom to Nigeria
On May 7, 2022, the World Health Organization (WHO) was informed of a confirmed case of Mpox in…
-
University of Oxford reported brain regions related to smell show decline following mild COVID-19
On Mar. 7, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
-
University of Oxford researchers created largest ever human family tree
On Feb. 24, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 heroes & Remembrance
Our Heroes and Remembrance illustration has Maurice Ralph Hilleman and John Enders, pioneering developers of common vaccines, and…
-
SIGA announced collaboration with Oxford University to expanded Access Protocol for Use of TPOXX in Central African Republic
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
-
SIGA supplied TPOXX (Tecovirimat) as compassionate treatment for Mpox case in the UK
On Jul. 29, 2021, SIGA Technologies announced that it had entered into a collaboration with Oxford University in…
-
Sanofi and GSK initiated global Phase 3 clinical efficacy study of COVID-19 vaccine candidate
On May 27, 2021, Sanofi and GlaxoSmithKline started enrolment in their Phase 3 clinical study to assess the…
-
Complete trial results of Novavax COVID-19 investigational vaccine posted to preprint server medRxiv
On May 21, 2021, Novavax announced that the full results from the Phase 3, randomized, observer-blinded, placebo-controlled trial…
-
Novavax announced participation in mix-and-match COVID-19 vaccine booster trial in the United Kingdom
On May 21, 2021, Novavax announced participation in a mix-and-match (vaccine interchangeability) COVID-19 vaccine booster trial that led…
-
EMA issued positive scientific opinion on GSK and Vir Biotechnology’s sotrovimab for the early treatment of COVID-19
On May 21, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency’s (EMA) Committee for Human Medicinal…
-
Medicago and GSK announced positive interim Phase 2 results for adjuvanted COVID-19 vaccine candidate
On May 18, 2021, GlaxoSmithKline and Medicago reported positive interim Phase 2 clinical trial safety and immunogenicity data for…
-
University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutation
On May 3, 2021, University of British Columbia (UBC) researchers were the first in the world to publish…
-
BioNTech updated on vaccine production status at Marburg manufacturing site
On Mar. 26, 2021, BioNTech announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19…
-
US, Chile and Peru interim trial data showed Oxford-AstraZeneca vaccine was safe and highly effective
On Mar. 22, 2021, Oxford University announced that a Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted…
-
Novavax confirmed ligh levels of efficacy against original and variant COVID-19 strains in UK and South Africa trials
On Mar. 11, 2021, Novavax announced final efficacy of 96.4% against mild, moderate and severe disease caused by…
-
Johnson & Johnson announced single-shot COVID-19 vaccine candidate received positive CHMP opinion
On Mar. 11, 2021, Johnson & Johnson announced that the Committee for Medicinal Products for Human Use (CHMP)…
-
New evidence COVID-19 antibodies, vaccines less effective against variants
On Mar. 4, 2021, researchers at the University School of Medicine in St. Louis announced that three new,…
-
CureVac and UK Government announced collaboration on development of vaccines against SARS-CoV-2 variants
On Feb. 5, 2021, CureVac announced that it had entered a collaboration with the UK Government to develop…
-
Oxford University vaccine effective against major B117 ‘Kent’ coronavirus strain circulating in the UK
On Feb. 5, 2021, Oxford University announced that a preprint of ongoing work to assess effectiveness of Oxford’s…
-
No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
On Jun. 5, 2020, the Chief Investigators of the randomised evaluation of COVid-19 thERapY (RECOVERY) trial on hydroxychloroquine…
-
The UK Global Vaccine Summit secured $74 billion in funding to support global vaccine supply and immunisation
On Jun. 4, 2020, the United Kingdom (UK) helped secure $7.4 billion in funding to support global vaccine…
-
Dementia gene raises risk of severe COVID-19
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
-
Analysis of COVID-19 genomes revealed large numbers of introductions to the UK in March, 2020
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
-
Abbott announced contract to supply millions of IgG lab-based antibody tests to UK government
On May 21, 2020, Abbott announced a government contract to supply millions of its laboratory-based IgG antibody tests…
-
AstraZeneca advanced response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
-
Baxter announced results of clinical trial on benefits of Dynamic Fluid Management in septic shock patients
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
-
Landmark partnership announced for development of COVID-19 vaccine
On Apr. 30, 2020, the University of Oxford announced an agreement with the UK-based global biopharmaceutical company AstraZeneca…
-
Five Oxford University COVID-19 projects received UK Research and Innovation funding
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
-
COVID-19 Therapeutics Accelerator awarded $20 million in initial grants to fund clinical trials
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…
